Skip to main content

Cearley Cassia's Form 4 filing

Icosavax, Inc.ICVX · filed Mar 9, 2022

Accession no.
0001209191-22-017635
Filed
Mar 9, 2022
Trade date
Mar 7, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. Open-market sales total $171.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cearley CassiaCIK 0001874017Officer (Chief Business Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 7, 2022Common StockSSaleDisposed−9,516$17.13F2−$163,009.0898,897Direct
Mar 7, 2022Common StockSSaleDisposed−484$17.81F3−$8,620.0498,413Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.71 and $17.63. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.78 and $17.88. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)